Table of Contents 1 Relevant Concept of Sorafenib 1.1 Indications of Sorafenib 1.2 Development of China’s Sorafenib Market 1.3 Governmental Approval of Sorafenib in China 1.4 The Impact of COVID-19 on China’s Sorafenib Market 2 Sales of Sorafenib in China, 2016-2020 2.1 Sales Value 2.1.1 Sales Value in China 2.1.2 Sales Value in China by Region 2.2 Sales Volume 2.2.1 Sales Volume in China 2.2.2 Sales Volume in China by Region 2.3 Sales of Sorafenib in China by Dosage Form, 2016-2020 2.3.1 Tablets 2.3.2 Other Dosage Forms 3 Analysis of Major Sorafenib Manufacturers in China, 2020 3.1 Analysis of Market Share 3.1.1 Market Share of Manufacturers by Sales Value 3.1.2 Market Share of Manufacturers by Sales Volume 3.2 Bayer AG 3.2.1 Company Profile 3.2.2 Sales of Sorafenib in China 3.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. 3.3.1 Company Profile 3.3.2 Sales of Sorafenib in China 4 Sales Price of Sorafenib of Different Companies in China, 2020-2021 4.1 Bayer AG (Nexavar®) 4.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. (Ligesitai®) 5 Prospects of China’s Sorafenib Market, 2021-2025 5.1 Influencing Factors for the Market Development 5.1.1 The Impact of COVID-19 on the Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information of Sorafenib in China Chart Sales Value of Sorafenib in China, 2016-2020 Chart Sales Volume of Sorafenib in China, 2016-2020 Chart Sales Volume of Sorafenib in China by Region, 2016-2020 Chart Sales Value of Sorafenib in China by Region, 2016-2020 Chart Market Share of Sorafenib Manufacturers in China by Sales Value, 2016-2020 Chart Sales Value and Volume of Sorafenib (of Bayer AG) in China, 2016-2020 Chart Sales Value and Volume of Sorafenib (of Jiangxi Shanxiang Pharmaceutical Co., Ltd.) in China, 2016-2020 Chart Sales Price of Sorafenib (of Bayer AG) in China, 2016-2020 Chart Sales Price of Sorafenib (of Jiangxi Shanxiang Pharmaceutical Co., Ltd.) in China, 2016-2020 Chart Forecast on Sales Value of Sorafenib in China, 2021-2025 Chart Forecast on Sales Volume of Sorafenib in China, 2021-2025

1 Bayer AG (Nexavar®) 2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. (Ligesitai®)